1. Corporate Officers - K
2. Keyes Jason A

Insider Trading History of Keyes Jason A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Keyes Jason A since 2019. This trader's CIK number is 1678152. At the time of last reporting, Keyes Jason A was the Chief Financial Officer of Blossomhill Therapeutics, Inc.. (stock ticker symbol BLSM). Also see all insider trading activities at Blossomhill Therapeutics, Inc..

Note that in the past Keyes Jason A also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Equillium, Inc. (EQ) by Keyes Jason A

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2025	EQ	0	$0	10,000	$6,500	0	$0
2024	EQ	0	$0	30,000	$23,800	0	$0
2022	EQ	0	$0	20,000	$57,850	0	$0
2021	EQ	0	$0	18,000	$107,913	0	$0
2020	EQ	0	$0	18,000	$85,096	0	$0
2019	EQ	0	$0	10,000	$37,920	0	$0

Yearly summary of insider trading at Blossomhill Therapeutics, Inc. (BLSM) by Keyes Jason A

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2026	BLSM	700	$11,200	0	$0	0	$0

Insider trading activities at 2 companies by Keyes Jason A:

1. Equillium, Inc. (EQ)

2. Blossomhill Therapeutics, Inc. (BLSM)

Table 1. Insider trading of Equillium, Inc. (EQ) by Keyes Jason A

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2025-01-23	EQ	Sale	10,000	.65	6,500
2024-11-14	EQ	Sale	10,000	.70	7,000
2024-09-26	EQ	Sale	10,000	.81	8,100
2024-07-16	EQ	Sale	10,000	.87	8,700
2022-08-29	EQ	Sale	7,000	2.83	19,810
2022-06-06	EQ	Sale	5,000	2.52	12,600
2022-04-04	EQ	Sale	8,000	3.18	25,440
2021-12-01	EQ	Sale	5,000	5.08	25,400
2021-09-27	EQ	Sale	8,000	6.74	53,928
2021-07-27	EQ	Sale	5,000	5.72	28,585
2020-12-23	EQ	Sale	8,000	4.74	37,912
2020-02-18	EQ	Sale	5,000	5.03	25,139
2020-01-21	EQ	Sale	5,000	4.41	22,045
2019-09-03	EQ	Sale	5,000	3.60	17,980
2019-08-01	EQ	Sale	5,000	3.99	19,940

Table 2. Insider trading of Blossomhill Therapeutics, Inc. (BLSM) by Keyes Jason A

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2026-08-10	BLSM	Buy	700	16.00	11,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Keyes Jason A (Chief Financial Officer of Blossomhill Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month